| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2001 | CN1281697A Multifunctional medicine |
| 01/31/2001 | CN1281696A Oral liquor for curing duodenal ulcer |
| 01/31/2001 | CN1061351C Intermediates diaza or oxadiazabicyclic compounds |
| 01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
| 01/31/2001 | CN1061348C New crystal modification of quinolinecarboxylic acid hydrochloride, process for its preparation and pharmaceutical formulations |
| 01/31/2001 | CN1061347C 抗真菌剂 Antifungal agents |
| 01/31/2001 | CN1061346C Diazabicycloalkene derivatives and use, and drug composition containing said derivatives |
| 01/31/2001 | CN1061341C 1-amino-ethylindole-derivatives |
| 01/31/2001 | CN1061339C Novel sulfonamide inhibitors of aspartyl protease |
| 01/31/2001 | CN1061256C External-use blood pressure reducing ointment |
| 01/31/2001 | CN1061248C Powder agent formula for curing acne and seborrhea and production method |
| 01/31/2001 | CN1061236C Ointment for curing eczema |
| 01/31/2001 | CN1061231C Preparing method for cataract eye drops and cataract eye drops prepared by said method |
| 01/31/2001 | CN1061213C Method for combating fish parasites |
| 01/30/2001 | US6180824 Alpha-alkyl-s-alkyl-homocysteine sulfoximines wherein alpha-alkyl contains 2 to 8 carbon atoms and s-alkyl contains 1 to 10 carbon atoms except for alpha-ethyl-methionine sulfoximine |
| 01/30/2001 | US6180816 Anti-viral compounds |
| 01/30/2001 | US6180815 Compounds which abrogate hemagglutinin-mediated fusion of virus-host membranes; treating influenza |
| 01/30/2001 | US6180805 Photochemical process for the production of previtamin D3 |
| 01/30/2001 | US6180803 Steroid drugs |
| 01/30/2001 | US6180793 Process for the preparation of a pharmacologically active substance |
| 01/30/2001 | US6180792 Drugs, antisecretory agents and hormone inhibitors for lh-rh |
| 01/30/2001 | US6180791 Synthesis of 8-substituted xanthines |
| 01/30/2001 | US6180787 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides |
| 01/30/2001 | US6180786 Antagonist for excitory amino acids |
| 01/30/2001 | US6180782 Preparation of clavulanate salts |
| 01/30/2001 | US6180781 Process for making mometasone furoate monohydrate |
| 01/30/2001 | US6180780 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 01/30/2001 | US6180773 The cc type chemokines belong to a family of polypeptides which have proven to be mediators of immune reactions, and which have antiviral activity with respect to hiv |
| 01/30/2001 | US6180766 Nucleosides and oligonucleotides containing boron clusters |
| 01/30/2001 | US6180687 In situ repairing detached retinal tissue |
| 01/30/2001 | US6180682 Buccal drug delivery system for use in male contraception |
| 01/30/2001 | US6180681 2-cyclopenten-1-one as an inducer of HSP70 |
| 01/30/2001 | US6180680 Cardiovascular disorders |
| 01/30/2001 | US6180679 Parasiticide |
| 01/30/2001 | US6180678 Use of adrafinil to treat behavioral problems in aged canines |
| 01/30/2001 | US6180677 Tyrosine-derived compounds as calcium channel antagonists |
| 01/30/2001 | US6180676 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/30/2001 | US6180675 IL-8 receptor antagonists |
| 01/30/2001 | US6180674 Therapy for skin disorders |
| 01/30/2001 | US6180673 Corneal subepithelial opacity (haze) inhibitor |
| 01/30/2001 | US6180671 Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
| 01/30/2001 | US6180669 Method for treatment of dermatological disorders |
| 01/30/2001 | US6180667 Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock |
| 01/30/2001 | US6180666 Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds |
| 01/30/2001 | US6180665 Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1- cyclopentylcarbonyl) tyrosine |
| 01/30/2001 | US6180664 Pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 01/30/2001 | US6180662 Mixture of cinnamic acid, antioxidant, enzyme, microbiocides and viricides |
| 01/30/2001 | US6180660 Cholesterol-lowering therapy |
| 01/30/2001 | US6180659 Using a dibenzo(b,f)-(oxepin or thiepin) compound |
| 01/30/2001 | US6180658 Method for counteracting blood platelet aggregation in a patient in need thereof |
| 01/30/2001 | US6180657 Melatonin derivatives for use in treating desynchronization disorders |
| 01/30/2001 | US6180656 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems |
| 01/30/2001 | US6180654 Heterocyclic nonnucleoside inhibitors of reverse transcriptase |
| 01/30/2001 | US6180651 Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
| 01/30/2001 | US6180650 Antiinflammatory agents; respiratory system disorders; skin disorders; antitumor agents |
| 01/30/2001 | US6180648 Analogs of cocaine |
| 01/30/2001 | US6180647 Gastrointestinal disorders; nervous system disorders |
| 01/30/2001 | US6180646 Retroviral protease inhibitors |
| 01/30/2001 | US6180645 Antiepilepic agent |
| 01/30/2001 | US6180644 Immunotherapeutic agents |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180639 Therapy for human immunodeficiency virus |
| 01/30/2001 | US6180637 Therapy for parkinson, alzheimer disease |
| 01/30/2001 | US6180636 Substituted pyrrolopyrimidines and processes for their preparation |
| 01/30/2001 | US6180635 Novel thieno(2,3-d)pyrimidinediones which exhibit pharmacological activity, in particular immunosuppressive activity; treating allograft rejection |
| 01/30/2001 | US6180634 Combination therapy for the treatment of AIDS |
| 01/30/2001 | US6180633 Drug resistance and multidrug resistance modulators |
| 01/30/2001 | US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation |
| 01/30/2001 | US6180631 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 01/30/2001 | US6180630 Tricyclic pyrazolo-pyridazinone analogues as GAGA-A receptor ligands |
| 01/30/2001 | US6180628 Compounds, compositions and methods for treating influenza |
| 01/30/2001 | US6180627 Antithrombotic agents |
| 01/30/2001 | US6180626 Oxaspirooctane derivatives to prevent retention of carcinomatous pleural effusion or carcinomatous ascites |
| 01/30/2001 | US6180625 Modulating and normalizing an impaired haemostatic balance in a mammal, which method comprises administering an effective amount of novel benzoxazin derivatives; anticoagulants |
| 01/30/2001 | US6180624 Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception |
| 01/30/2001 | US6180623 Used as analgesics and anti-pruritic agents |
| 01/30/2001 | US6180621 Administering to warm-blooded animals for treatment and prevention of infectious diseases caused by helicobacter pylori |
| 01/30/2001 | US6180620 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
| 01/30/2001 | US6180619 Prenyl transferase inhibitors |
| 01/30/2001 | US6180618 Propanolamine derivatives linked to bile acids, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/30/2001 | US6180617 Method for reducing absorption of undesired lipids in the gastrointestinal tract |
| 01/30/2001 | US6180616 Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function |
| 01/30/2001 | US6180615 Propargyl phenyl ether A2A receptor agonists |
| 01/30/2001 | US6180611 Inhibitors of matrix metalloproteinases and tumor necrosis factor |
| 01/30/2001 | US6180599 May include lectins and/or fluoride in addition to medium-chain fatty acids; toothpaste, spray, gum |
| 01/30/2001 | US6180597 Useful in treating or preventing conditions such as pulmonary hypertension, ischemic stroke, impotence, heart failure, hypoxia-induced conditions, insulin deficiency, progressive renal disease, gastric or esophageal motility syndrome, etc. |
| 01/30/2001 | US6180577 Anti-germ attachment—composition |
| 01/30/2001 | US6180403 Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| 01/30/2001 | US6180402 Method for inhibiting apoptosis induced by photodynamic therapy using a cysteine or serine protease inhibitor |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180362 Peptides which inhibit ras protein activity, their preparation and use |
| 01/30/2001 | US6180356 Membrane pore inhibiting agents for treating infection |
| 01/30/2001 | US6180355 Method for diagnosing and treating chronic pelvic pain syndrome |
| 01/30/2001 | US6180353 Nucleotide sequences associated with suppression of transcription binding protein associated with apoptosis; for the treatment and prevention defects associated with apoptosis |
| 01/30/2001 | US6180142 Reduction of surfactant inactivation in pulmonary surfactant therapy |
| 01/30/2001 | US6180141 Composite gel microparticles as active principle carriers |
| 01/30/2001 | US6180140 Modified amino acids for drug delivery |
| 01/30/2001 | US6180139 Composition and method for treating nonalcoholic steatohepatitis |
| 01/30/2001 | US6180136 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |